Table 2.
ACS subgroups Vs polymorphisms distribution
| Cases | P value (< 0.05) | |||||
|---|---|---|---|---|---|---|
| CYP2C19*2 681G>A |
GG % | GA % | AA % | G allele % | A allele % | 0.002** |
| ST (+) | 4 | 80 | 16 | 44 | 56 | |
| ST (−) | 9.1 | 84.85 | 6.06 | 51.5 | 48.5 | |
| CYP2C19*3 636G>A |
GG % | GA % | AA % | G allele % | A allele % | 0.04* |
| ST (+) | 5.26 | 73.68 | 21.06 | 42.1 | 57.9 | |
| ST (−) | 3.03 | 75.76 | 21.21 | 40.9 | 59.1 | |
| CYP2C19*17 − 806 C>T |
CC % | CT % | TT % | C allele % | T allele % | 0.3 |
| ST (+) | 30 | 50 | 20 | 55 | 45 | |
| ST (−) | 10.87 | 69.57 | 19.56 | 47 | 53 | |
ST (+): Acute Coronary Syndromes with ST segment elevation; ST (−): Acute Coronary Syndromes without ST segment elevation
*Statistically significant (Chi square test)